Phase I Study of TAK-701 in Adult Patients With Advanced Nonhematological Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Advanced Solid Tumors
Related studies linked through entity extraction aliases.
Dose Escalation Study of ARQ 197 in Combination With Sorafenib in Adult Patients With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
A Phase 1 Study of AMG 208 in Subjects With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
A Phase 1, Multicenter, Open-Label, Dose-Escalation, Safety, Pharmacokinetic, and Pharmacodynamic Study of E6201 in Subjects With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Study of IMC-1121B in Patients With Tumors That Have Not Responded to Therapy
- Status
- COMPLETED
- Phase
- PHASE1
Multiple Dose Study In Cancer Patients: Safety and Tolerability of BMS-754807 in Combination With Paclitaxel and Carboplatin in Patients With Advanced or Metastatic Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Ascending Multiple-Dose Study of BMS-817378 in Subjects With Advanced Cancers
- Status
- WITHDRAWN
- Phase
- PHASE1
Study of Plitidepsin in Combination With Sorafenib or Gemcitabine in Patients With Advanced Solid Tumors or Lymphomas
- Status
- COMPLETED
- Phase
- PHASE1
A Study of IMC-A12 Every 2 Weeks in Patients With Tumors Who No Longer Respond to Treatment or No Treatment is Available
- Status
- COMPLETED
- Phase
- PHASE1
A Study of IMC-A12 in Participants With Tumors Who No Longer Respond to Treatment or For Whom No Treatment is Available
- Status
- COMPLETED
- Phase
- PHASE1
Phase I AZD2281/Cisplatin in Advanced Solid Tumour Patients
- Status
- COMPLETED
- Phase
- PHASE1
Safety Study of IMC-18F1,to Treat Advanced Solid Tumors in Subjects That no Longer Respond to Standard Therapy
- Status
- COMPLETED
- Phase
- PHASE1
Phase 1 Study of the Effect of Ketoconazole on the PK of Multiple Doses of Cediranib in Patients With Solid Tumours
- Status
- COMPLETED
- Phase
- PHASE1
Phase I Study of Intravenous Lipotecan® (TLC388 HCl for Injection) in Patients With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
A Phase 1 Dose-escalation Study of OSI-906 and Erlotinib (Tarceva®)
- Status
- COMPLETED
- Phase
- PHASE1
Phase I Safety Study of the Drug MM-121 in Patients With Advanced Solid Tumors Resisting Ordinary Treatment
- Status
- COMPLETED
- Phase
- PHASE1
Pharmacokinetic Study To Evaluate Effect of Food and Diurnal Variation on ABT-869
- Status
- COMPLETED
- Phase
- PHASE1
Phase I Study of U3P1287/01, Including Patients With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Study Of CP-751,871 In Combination With Sunitinib In Patients With Advanced Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1
Phase 1b Study of Indibulin in Combination With Capecitabine in Advanced Solid Tumors
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2